Impact of Pretransplantation Risk Factors on Post Transplantation Outcome of Patients with Acute Myeloid Leukemia in Remission after Haploidentical Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Impact of Pretransplantation Risk Factors on Post Transplantation Outcome of Patients with Acute Myeloid Leukemia in Remission after Haploidentical Hematopoietic Stem Cell Transplantation

Published:2013-02 Issue:2 Volume:19 Page:283-290
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Wang Yu,Liu Dai-Hong,Liu Kai-Yan,Xu Lan-Ping,Zhang Xiao-Hui,Han Wei,Chen Huan,Chen Yu-Hong,Huang Xiao-Jun

Funder

National Natural Science Foundation of China

National High-tech R&D Program of China

Leading Program of Clinical Faculty accredited by the Ministry of Health of China

National Scientific Major Program-major new drug formulation

Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461);Byrd;Blood,2002

2. Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience;Jourdan;J Clin Oncol,2005

3. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials;Koreth;JAMA,2009

5. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse;Aversa;J Clin Oncol,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study;eJHaem;2024-07-08

2. Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission;Cancer Medicine;2024-02

3. MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study;Blood Cancer Journal;2024-01-17

4. Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission;Annals of Hematology;2023-06-21

5. Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment;Cancer Communications;2022-10-23